AAAAAA

   
Results: 1-10 |
Results: 10
NEOADJUVANT HORMONAL-THERAPY - THE CANADIAN EXPERIENCE
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y BELANGER A CANDAS B
Citation: F. Labrie et al., NEOADJUVANT HORMONAL-THERAPY - THE CANADIAN EXPERIENCE, Urology, 49(3A), 1997, pp. 56-64
DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN
Authors: LABRIE F CANDAS B CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M
Citation: F. Labrie et al., DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN, Urology, 47(2), 1996, pp. 212-217
THE IMPACT OF FAMILY HISTORY ON EARLY DETECTION OF PROSTATE-CANCER
Authors: NAROD SA DUPONT A CUSAN L DIAMOND P GOMEZ JL SUBURU R LABRIE F
Citation: Sa. Narod et al., THE IMPACT OF FAMILY HISTORY ON EARLY DETECTION OF PROSTATE-CANCER, Nature medicine, 1(2), 1995, pp. 99-101
DOWNSTAGING BY COMBINATION THERAPY WITH FLUTAMIDE AND AN LHRH AGONISTBEFORE RADICAL PROSTATECTOMY
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y CANDAS B
Citation: F. Labrie et al., DOWNSTAGING BY COMBINATION THERAPY WITH FLUTAMIDE AND AN LHRH AGONISTBEFORE RADICAL PROSTATECTOMY, Cancer surveys, 23, 1995, pp. 149-156
STRATIFICATION OF STAGE D2 PROSTATE-CANCER PATIENTS BY A DISEASE AGGRESSIVENESS SCORE AND ITS USE IN EVALUATING DISEASE RESPONSE AND OUTCOME TO COMBINATION HORMONAL TREATMENT (GNRH-A PLUS FLUTAMIDE)
Authors: KOUTSILIERIS M DUPONT A GOMEZ J CUSAN L SUBURU R DIAMOND P LABRIE F
Citation: M. Koutsilieris et al., STRATIFICATION OF STAGE D2 PROSTATE-CANCER PATIENTS BY A DISEASE AGGRESSIVENESS SCORE AND ITS USE IN EVALUATING DISEASE RESPONSE AND OUTCOME TO COMBINATION HORMONAL TREATMENT (GNRH-A PLUS FLUTAMIDE), Anticancer research, 14(2B), 1994, pp. 627-634
DOWN-STAGING OF EARLY-STAGE PROSTATE-CANCER BEFORE RADICAL PROSTATECTOMY - THE FIRST RANDOMIZED TRIAL OF NEOADJUVANT COMBINATION THERAPY WITH FLUTAMIDE AND A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y CANDAS B
Citation: F. Labrie et al., DOWN-STAGING OF EARLY-STAGE PROSTATE-CANCER BEFORE RADICAL PROSTATECTOMY - THE FIRST RANDOMIZED TRIAL OF NEOADJUVANT COMBINATION THERAPY WITH FLUTAMIDE AND A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST, Urology, 44(6A), 1994, pp. 29-37
OPTIMIZED STRATEGY FOR DETECTION OF EARLY-STAGE, CURABLE PROSTATE-CANCER - ROLE OF PRESCREENING WITH PROSTATE-SPECIFIC ANTIGEN
Authors: LABRIE F DUPONT A SUBURU R CUSAN L GOMEZ JL KOUTSILIERIS M DIAMOND P EMOND J LEMAY M CANDAS B
Citation: F. Labrie et al., OPTIMIZED STRATEGY FOR DETECTION OF EARLY-STAGE, CURABLE PROSTATE-CANCER - ROLE OF PRESCREENING WITH PROSTATE-SPECIFIC ANTIGEN, Clinical and investigative medicine, 16(6), 1993, pp. 425-439
DOWNSTAGING OF LOCALIZED PROSTATE-CANCER BY NEOADJUVANT THERAPY WITH FLUTAMIDE AND LUPRON - THE FIRST CONTROLLED AND RANDOMIZED TRIAL
Authors: LABRIE F DUPONT A CUSAN L GOMEZ J DIAMOND P KOUTSILIERIS M SUBURU R FRADET Y LEMAY M TETU B EMOND J CANDAS B
Citation: F. Labrie et al., DOWNSTAGING OF LOCALIZED PROSTATE-CANCER BY NEOADJUVANT THERAPY WITH FLUTAMIDE AND LUPRON - THE FIRST CONTROLLED AND RANDOMIZED TRIAL, Clinical and investigative medicine, 16(6), 1993, pp. 499-509
SERUM PROSTATE-SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER - REPLY
Authors: LABRIE F DUPONT A SUBURU R CUSAN L TREMBLAY M GOMEZ JL EMOND J
Citation: F. Labrie et al., SERUM PROSTATE-SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER - REPLY, The Journal of urology, 149(5), 1993, pp. 1150-1150
COMBINATION THERAPY WITH FLUTAMIDE AND THE LHRH AGONIST [D-TRP(6), DES-GLY-NH(2)(10)]LHRH ETHYLAMIDE IN STAGE-C PROSTATIC-CARCINOMA
Authors: DUPONT A CUSAN L GOMEZ JL KOUTSILIERIS M SUBURU R EMOND J LABRIE F
Citation: A. Dupont et al., COMBINATION THERAPY WITH FLUTAMIDE AND THE LHRH AGONIST [D-TRP(6), DES-GLY-NH(2)(10)]LHRH ETHYLAMIDE IN STAGE-C PROSTATIC-CARCINOMA, British Journal of Urology, 72(5), 1993, pp. 629-634
Risultati: 1-10 |